University Hospitals Brain Health & Memory Center is now treating patients with KISUNLA™ (donanemab), a Food and Drug ...

Neuro Thrive is a natural dietary capsule designed to enhance the overall performance of your brain. It addresses the common concerns that impact the normal functioning of your brain and resolves them ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

The first new treatment for Alzheimer's disease for nearly 20 years has been approved ... the drug, given as a monthly infusion, was not better at slowing the deterioration of memory and thinking ...

“It’s a major milestone in demonstrating the ability to restore memory function in ... when the U.S. Food and Drug Administration (FDA) approved deep-brain stimulation as a treatment for ...

Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment ...

U.S. authorities gave full approval to lecanemab, sold as Leqembi, in July. When a person develops Alzheimer’s disease, nerve cells in the brain break ... a decline in memory, judgment and ...